Author:
Amrein R.,Allen S.R.,Guentert T.W.,Hartmann D.,Lorscheid T.,Schoerlin M.-P.,Vranesic D.
Abstract
The older monoamine oxidase inhibitors (MAOIs) are mechanism-based, irreversible inhibitors of MAO; most inhibit both the A and B forms of MAO. Several of the drugs are hydrazine derivatives which have non-specific effects other than MAO inhibition. These properties convey disadvantages, which may be seen as serious, though infrequent, adverse events — the ‘cheese effect’, hepatotoxicity, amphetamine-like activity, orthostatic hypotension and anticholinergic effects. New, reversible MAOIs stem from a variety of chemical classes and are more specific in their effects, with relatively rapid onset of action, direct relationship between plasma concentration and pharmacological effect, and no prolonged carry-over phenomena.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Reference35 articles.
1. Schoerlin M.-P. & Guentert T.W. (1989) Pharmakokinetik und Metabolismus reversibler MAO-A Hemmer beim Menschen. Psychiatrische Praxis (in press).
2. Atypical Facial Pain and Depression
3. Monoamine oxidase inhibitors: a review;Tollefson;Journal of Clinical Psychiatry,1983
4. Disposition kinetics of moclobemide, a monoamine oxidase-A enzyme inhibitor: Single and multiple dosing in normal subjects
5. Suicide enzyme inactivators
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献